Teva Charged in Price-Fixing Probe of Generic Drug Makers
- August 28, 2020
Teva Pharmaceuticals USA Inc. (Teva) is the seventh company to face allegations that it participated in a far-reaching conspiracy to fix prices for generic drugs, the Department of Justice (DOJ) announced August 26.
ARTICLE TAGS
You must be logged in to access this content.